Chlorine in PDB 4zbq: Crystal Structure of Equine Serum Albumin in Complex with Diclofenac
Protein crystallography data
The structure of Crystal Structure of Equine Serum Albumin in Complex with Diclofenac, PDB code: 4zbq
was solved by
B.Sekula,
A.Bujacz,
G.Bujacz,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
40.67 /
1.92
|
Space group
|
P 61
|
Cell size a, b, c (Å), α, β, γ (°)
|
93.580,
93.580,
141.070,
90.00,
90.00,
120.00
|
R / Rfree (%)
|
16.9 /
19.9
|
Chlorine Binding Sites:
The binding sites of Chlorine atom in the Crystal Structure of Equine Serum Albumin in Complex with Diclofenac
(pdb code 4zbq). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total 4 binding sites of Chlorine where determined in the
Crystal Structure of Equine Serum Albumin in Complex with Diclofenac, PDB code: 4zbq:
Jump to Chlorine binding site number:
1;
2;
3;
4;
Chlorine binding site 1 out
of 4 in 4zbq
Go back to
Chlorine Binding Sites List in 4zbq
Chlorine binding site 1 out
of 4 in the Crystal Structure of Equine Serum Albumin in Complex with Diclofenac
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 1 of Crystal Structure of Equine Serum Albumin in Complex with Diclofenac within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl601
b:65.2
occ:1.00
|
CL2
|
A:DIF601
|
0.0
|
65.2
|
1.0
|
C2
|
A:DIF601
|
1.7
|
50.1
|
1.0
|
C1
|
A:DIF601
|
2.6
|
49.9
|
1.0
|
C3
|
A:DIF601
|
2.8
|
50.3
|
1.0
|
C9
|
A:DIF601
|
3.0
|
48.0
|
1.0
|
N1
|
A:DIF601
|
3.2
|
48.6
|
1.0
|
C8
|
A:DIF601
|
3.2
|
47.5
|
1.0
|
CA
|
A:VAL387
|
3.4
|
39.6
|
1.0
|
OG
|
A:SER448
|
3.6
|
45.7
|
1.0
|
CG2
|
A:VAL387
|
3.6
|
43.5
|
1.0
|
CB
|
A:SER448
|
3.7
|
38.9
|
1.0
|
CB
|
A:ASN390
|
3.7
|
42.0
|
1.0
|
CB
|
A:VAL387
|
3.8
|
41.8
|
1.0
|
C10
|
A:DIF601
|
3.8
|
47.8
|
1.0
|
O
|
A:VAL387
|
3.9
|
42.0
|
1.0
|
CG1
|
A:VAL387
|
3.9
|
43.0
|
1.0
|
C6
|
A:DIF601
|
3.9
|
51.5
|
1.0
|
C4
|
A:DIF601
|
4.1
|
50.4
|
1.0
|
C
|
A:VAL387
|
4.1
|
42.5
|
1.0
|
C7
|
A:DIF601
|
4.3
|
47.1
|
1.0
|
N
|
A:VAL387
|
4.3
|
40.7
|
1.0
|
O
|
A:LEU386
|
4.4
|
40.1
|
1.0
|
SG
|
A:CYS391
|
4.4
|
45.9
|
1.0
|
C5
|
A:DIF601
|
4.5
|
51.6
|
1.0
|
CG
|
A:ASN390
|
4.5
|
46.3
|
1.0
|
ND2
|
A:ASN390
|
4.7
|
48.3
|
1.0
|
C
|
A:LEU386
|
4.7
|
40.6
|
1.0
|
N
|
A:CYS391
|
4.7
|
40.8
|
1.0
|
CA
|
A:ASN390
|
4.7
|
40.4
|
1.0
|
C11
|
A:DIF601
|
4.7
|
48.8
|
1.0
|
C12
|
A:DIF601
|
4.9
|
46.4
|
1.0
|
C
|
A:ASN390
|
5.0
|
41.0
|
1.0
|
|
Chlorine binding site 2 out
of 4 in 4zbq
Go back to
Chlorine Binding Sites List in 4zbq
Chlorine binding site 2 out
of 4 in the Crystal Structure of Equine Serum Albumin in Complex with Diclofenac
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 2 of Crystal Structure of Equine Serum Albumin in Complex with Diclofenac within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl601
b:66.8
occ:1.00
|
CL4
|
A:DIF601
|
0.0
|
66.8
|
1.0
|
C4
|
A:DIF601
|
1.7
|
50.4
|
1.0
|
C5
|
A:DIF601
|
2.7
|
51.6
|
1.0
|
C3
|
A:DIF601
|
2.7
|
50.3
|
1.0
|
N1
|
A:DIF601
|
3.0
|
48.6
|
1.0
|
O
|
A:HOH701
|
3.1
|
47.8
|
1.0
|
O2
|
A:DIF601
|
3.3
|
61.4
|
1.0
|
CD2
|
A:LEU406
|
3.7
|
42.0
|
1.0
|
CD1
|
A:LEU452
|
3.9
|
36.3
|
0.5
|
C6
|
A:DIF601
|
4.0
|
51.5
|
1.0
|
CD2
|
A:LEU452
|
4.0
|
37.2
|
0.5
|
C8
|
A:DIF601
|
4.0
|
47.5
|
1.0
|
C2
|
A:DIF601
|
4.0
|
50.1
|
1.0
|
CD1
|
A:LEU406
|
4.1
|
44.7
|
1.0
|
CD1
|
A:LEU429
|
4.2
|
48.9
|
1.0
|
CB
|
A:LEU429
|
4.2
|
44.3
|
1.0
|
NH1
|
A:ARG409
|
4.2
|
53.7
|
1.0
|
CD2
|
A:LEU429
|
4.2
|
48.6
|
1.0
|
CG
|
A:LEU452
|
4.3
|
35.4
|
0.5
|
CG
|
A:LEU429
|
4.4
|
45.8
|
1.0
|
C14
|
A:DIF601
|
4.5
|
60.1
|
1.0
|
C1
|
A:DIF601
|
4.5
|
49.9
|
1.0
|
CG
|
A:LEU406
|
4.5
|
40.6
|
1.0
|
CD2
|
A:LEU452
|
4.5
|
37.6
|
0.5
|
CD1
|
A:LEU452
|
4.6
|
36.1
|
0.5
|
OD1
|
A:ASN390
|
4.7
|
45.9
|
1.0
|
C9
|
A:DIF601
|
4.7
|
48.0
|
1.0
|
CZ
|
A:PHE402
|
4.8
|
42.1
|
1.0
|
C7
|
A:DIF601
|
4.9
|
47.1
|
1.0
|
|
Chlorine binding site 3 out
of 4 in 4zbq
Go back to
Chlorine Binding Sites List in 4zbq
Chlorine binding site 3 out
of 4 in the Crystal Structure of Equine Serum Albumin in Complex with Diclofenac
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 3 of Crystal Structure of Equine Serum Albumin in Complex with Diclofenac within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl602
b:80.8
occ:1.00
|
CL2
|
A:DIF602
|
0.0
|
80.8
|
1.0
|
C2
|
A:DIF602
|
1.8
|
58.5
|
1.0
|
C3
|
A:DIF602
|
2.8
|
53.3
|
1.0
|
C1
|
A:DIF602
|
2.8
|
56.4
|
1.0
|
N1
|
A:DIF602
|
3.0
|
53.5
|
1.0
|
C8
|
A:DIF602
|
3.3
|
57.7
|
1.0
|
O
|
A:ASP401
|
3.6
|
36.2
|
1.0
|
C9
|
A:DIF602
|
3.7
|
52.6
|
1.0
|
CB
|
A:ASP401
|
3.7
|
43.5
|
1.0
|
CD
|
A:LYS544
|
3.8
|
55.9
|
1.0
|
NZ
|
A:LYS544
|
3.9
|
63.2
|
1.0
|
C7
|
A:DIF602
|
4.0
|
59.1
|
1.0
|
CG
|
A:ASP401
|
4.1
|
49.3
|
1.0
|
C6
|
A:DIF602
|
4.1
|
54.8
|
1.0
|
CG1
|
A:VAL397
|
4.1
|
48.2
|
1.0
|
C
|
A:ASP401
|
4.2
|
39.3
|
1.0
|
C4
|
A:DIF602
|
4.2
|
52.5
|
1.0
|
CG2
|
A:VAL397
|
4.2
|
44.9
|
1.0
|
CB
|
A:VAL397
|
4.3
|
45.3
|
1.0
|
CE
|
A:LYS544
|
4.5
|
57.6
|
1.0
|
CA
|
A:ASP401
|
4.5
|
40.3
|
1.0
|
C13
|
A:DIF602
|
4.5
|
64.3
|
1.0
|
OD1
|
A:ASP401
|
4.5
|
56.0
|
1.0
|
OD2
|
A:ASP401
|
4.6
|
55.8
|
1.0
|
CB
|
A:ALA405
|
4.6
|
38.0
|
1.0
|
C10
|
A:DIF602
|
4.6
|
53.5
|
1.0
|
C5
|
A:DIF602
|
4.7
|
50.6
|
1.0
|
CG
|
A:LYS544
|
4.7
|
50.5
|
1.0
|
CD1
|
A:LEU393
|
4.8
|
50.4
|
1.0
|
C12
|
A:DIF602
|
4.9
|
57.9
|
1.0
|
|
Chlorine binding site 4 out
of 4 in 4zbq
Go back to
Chlorine Binding Sites List in 4zbq
Chlorine binding site 4 out
of 4 in the Crystal Structure of Equine Serum Albumin in Complex with Diclofenac
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 4 of Crystal Structure of Equine Serum Albumin in Complex with Diclofenac within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl602
b:63.9
occ:1.00
|
CL4
|
A:DIF602
|
0.0
|
63.9
|
1.0
|
C4
|
A:DIF602
|
1.8
|
52.5
|
1.0
|
C3
|
A:DIF602
|
2.7
|
53.3
|
1.0
|
C5
|
A:DIF602
|
2.8
|
50.6
|
1.0
|
N1
|
A:DIF602
|
3.0
|
53.5
|
1.0
|
CB
|
A:LYS540
|
3.3
|
52.4
|
1.0
|
CG2
|
A:VAL408
|
3.4
|
37.0
|
1.0
|
O
|
A:HOH808
|
3.5
|
46.4
|
1.0
|
CA
|
A:LYS540
|
3.6
|
50.5
|
1.0
|
O
|
A:LYS540
|
3.6
|
45.5
|
1.0
|
CB
|
A:VAL408
|
3.7
|
35.9
|
1.0
|
C8
|
A:DIF602
|
3.8
|
57.7
|
1.0
|
CA
|
A:ALA405
|
3.9
|
36.1
|
1.0
|
CG1
|
A:VAL408
|
3.9
|
36.3
|
1.0
|
C
|
A:LYS540
|
3.9
|
47.3
|
1.0
|
C6
|
A:DIF602
|
4.1
|
54.8
|
1.0
|
C2
|
A:DIF602
|
4.1
|
58.5
|
1.0
|
C9
|
A:DIF602
|
4.2
|
52.6
|
1.0
|
O
|
A:ASN404
|
4.4
|
34.4
|
1.0
|
N
|
A:ALA405
|
4.5
|
35.5
|
1.0
|
CB
|
A:ALA405
|
4.5
|
38.0
|
1.0
|
CG
|
A:LYS540
|
4.6
|
55.8
|
1.0
|
C1
|
A:DIF602
|
4.6
|
56.4
|
1.0
|
O
|
A:ALA405
|
4.6
|
35.3
|
1.0
|
CB
|
A:LEU543
|
4.6
|
40.1
|
1.0
|
C
|
A:ASN404
|
4.7
|
35.4
|
1.0
|
O2
|
A:DIF602
|
4.7
|
70.1
|
1.0
|
C
|
A:ALA405
|
4.7
|
36.4
|
1.0
|
CD
|
A:LYS540
|
4.9
|
60.8
|
1.0
|
N
|
A:LYS540
|
4.9
|
48.9
|
1.0
|
C7
|
A:DIF602
|
5.0
|
59.1
|
1.0
|
|
Reference:
B.Sekula,
A.Bujacz.
Structural Insights Into the Competitive Binding of Diclofenac and Naproxen By Equine Serum Albumin. J.Med.Chem. V. 59 82 2016.
ISSN: ISSN 0022-2623
PubMed: 26652101
DOI: 10.1021/ACS.JMEDCHEM.5B00909
Page generated: Fri Jul 26 04:30:45 2024
|